Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis

Systemic sclerosis (SSc) is the most severe systemic autoimmune disease with currently no cure. Intravenous immunoglobulins (IVIg) are an attractive candidate in this disease to counteract inflammation and fibrosis but data are scarce and conflicting. This study, assessed the effects of IVIg in a mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Speca, Silvia, Farhat, Meryem-Maud, Jendoubi, Manel, Guerrier, Thomas, Sanges, Sébastien, Staumont-Sallé, Delphine, Hachulla, Eric, Dubucquoi, Sylvain, Sobanski, Vincent, Collet, Aurore, Launay, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497569/
https://www.ncbi.nlm.nih.gov/pubmed/37700078
http://dx.doi.org/10.1038/s41598-023-42464-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497569/
https://www.ncbi.nlm.nih.gov/pubmed/37700078
http://dx.doi.org/10.1038/s41598-023-42464-9

Ejemplares similares